Sandoz INC
Pharmaceutical company
Based in NJ
🤖
AI Overview
With $2.4M in lobbying spend across 11 quarterly filings, Sandoz INC is a significant lobbying presence. Their lobbying covers 2 issue areas. Active from 2023 to 2025.
$2.4M
Total Spend
3
Years Active
1
Firms Hired
3
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2023 | $80K |
| 2024 | $1.2M |
| 2025 | $1.1M |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid
- •Issues related to generic drug supply chain and shortage proposals, interchangeability proposals and PBM proposals
- •Generic drug supply chain and shortage proposals, interchangeability proposals and PBM proposals
- •Issues related to biosimilar legislation; PBM reform legislation; Generics sustainability and supply chain; House Oversight Committee Minority request re Amoxicillin shortage
- •Congressional outreach re: PBM reform legislation (biosimilars); Generics sustainability and supply chain; Biosimilars sustainability; Biosimilars interchangeability legislation
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.